Acute pharmacological conversion of atrial fibrillation to sinus rhythm: is short-term symptomatic therapy worth it? A report from the December 2007 Meeting of the Cardiovascular and Renal Drugs Advisory Committee of the Food and Drug Administration.
University of Colorado Denver, School of Medicine, Denver, CO 80203, USA. will.hiatt@uchsc.edu
William R
WR
Hiatt
A Michael
AM
Lincoff
Robert A
RA
Harrington
D026683:Advisory Committees; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D001281:Atrial Fibrillation / Q000188:drug therapy*; D006801:Humans; D014481:United States; D014486:United States Food and Drug Administration
D000889:Anti-Arrhythmia Agents